Active Pharmaceutical Ingredient Incorporated Supramolecular Materials as Antibacterial Agents

Abstract

Active pharmaceutical ingredient (API) metronidazole incorporated supramolecular materials based on pyridyl-carbamate and their N-oxide derivatives exhibited significant activity against anaerobic bacterium (P. gingivalis) and were non-toxic to mammalian fibroblast cells. The findings demonstrate a promising approach for developing API-incorporated supramolecular materials as antibacterial agents.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Communication
Submitted
14 Apr 2026
Accepted
26 May 2026
First published
27 May 2026

Chem. Commun., 2026, Accepted Manuscript

Active Pharmaceutical Ingredient Incorporated Supramolecular Materials as Antibacterial Agents

S. S. Jayabhavan, A. Chandramouli, R. Jayakumar and K. K. Damodaran, Chem. Commun., 2026, Accepted Manuscript , DOI: 10.1039/D6CC02299E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements